If you like this story please SHARE!

Pfizer's AU$9.4 billion acquisition of Arena "shows big pharma's interest in cannabinoid medicines"

Arena was CBDX's fourth-largest holdings at the end of November, at 11.8%.

Pfizer Inc's (NYSE:PFE) agreed acquisition of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) for almost double the closing price of the stock in the previous trading sessions, is just the latest case of big pharma's confidence to get into cannabinoid-based research, said the manager of an